Tuberculosis: Commentary on a Reemergent Killer
暂无分享,去创建一个
[1] J. Thomas,et al. A method for estimating the prevalence of tuberculosis infection. , 1975, American journal of epidemiology.
[2] P. D. Hart,et al. The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in induced tuberculin sensitivity and to technical variations in the vaccines , 1967 .
[3] W. Jacobs,et al. Introduction of foreign DNA into mycobacteria using a shuttle phasmid , 1987, Nature.
[4] I. Orme. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines , 1988, Infection and immunity.
[5] R. Henderson,et al. Expanded programme on immunization. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.
[6] M. Sogin,et al. Direct detection of Mycobacterium tuberculosis in clinical specimens by DNA amplification , 1990, Journal of clinical microbiology.
[7] E. C. Mooney,et al. The white plague. , 1979, American heritage.
[8] V. Kindler,et al. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection , 1989, Cell.
[9] J. Sbarbaro. The patient-physician relationship: compliance revisited. , 1990, Annals of allergy.
[10] W. Fox. Compliance of patients and physicians: experience and lessons from tuberculosis-II. , 1983, British medical journal.
[11] P. G. Smith,et al. Epidemiologic Problems and Prospects , 1989 .
[12] R. Locksley,et al. Tumour necrosis factor α restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice , 1992, Nature.
[13] J. Phair,et al. Airborne Contagion and Air Hygiene , 1955 .
[14] S. Petroff,et al. BIOLOGICAL STUDIES OF THE TUBERCLE BACILLUS : III. DISSOCIATION AND PATHOGENICITY OF THE R AND S VARIANTS OF THE HUMAN TUBERCLE BACILLUS (H37) , 1934 .
[15] D. Snider,et al. Tuberculosis in patients with human immunodeficiency virus infection. , 1991, The New England journal of medicine.
[16] W. Jacobs,et al. Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guérin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Bernardo,et al. Tuberculosis screening in Boston's homeless shelters. , 1986, Public health reports.
[18] G. Comstock. Identification of an effective vaccine against tuberculosis. , 1988, The American review of respiratory disease.
[19] G. Rook,et al. The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. , 1987, Immunology.
[20] M. Caldwell. The last crusade : the war on consumption, 1862-1954 , 1989 .
[21] P. Brennan,et al. Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. , 1990, Journal of immunology.
[22] W. Jacobs,et al. Lysogeny and transformation in mycobacteria: stable expression of foreign genes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Chaisson,et al. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. , 1991, The New England journal of medicine.
[24] D. Soll,et al. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis , 1991, Journal of clinical microbiology.
[25] P. Shankar,et al. Identification of Mycobacterium tuberculosis by polymerase chain reaction , 1990, The Lancet.
[26] ten Dam Hg,et al. Does BCG vaccination protect the newborn and young infants , 1980 .
[27] W. Willett,et al. A case-control study of BCG and childhood tuberculosis in Cali, Colombia. , 1985, International journal of epidemiology.
[28] P. Barnes,et al. Mycobacterial disease in patients with human immunodeficiency virus infection. , 1989, Archives of internal medicine.
[29] W. Boom,et al. Human Mycobacterium tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes , 1991, Infection and immunity.
[30] National action plan to combat multidrug-resistant tuberculosis. , 1992, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[31] C. Murray,et al. Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries , 1991, The Lancet.
[32] K. Hyams,et al. Tuberculin skin testing in US Navy and Marine Corps personnel and recruits, 1980-86. , 1990, American journal of public health.
[33] Selman A. Waksman,et al. The Conquest of Tuberculosis , 2021 .
[34] S. Kaufmann,et al. CD8+ T lymphocytes in intracellular microbial infections. , 1988, Immunology today.
[35] B. Bloom,et al. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages , 1992, The Journal of experimental medicine.
[36] J. Garthwaite. Glutamate, nitric oxide and cell-cell signalling in the nervous system , 1991, Trends in Neurosciences.
[37] P. Barnes,et al. Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. , 1989, Journal of immunology.
[38] D. Risser,et al. An outbreak of tuberculosis in a shelter for homeless men. A description of its evolution and control. , 1991, The American review of respiratory disease.
[39] S. Vermund,et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. , 1989, The New England journal of medicine.
[40] T. To,et al. The significance of the tuberculin skin test in elderly persons. , 1987, Annals of internal medicine.
[41] E. Nardell,et al. Exogenous reinfection with tuberculosis in a shelter for the homeless. , 1986, The New England journal of medicine.
[42] D. Snider,et al. Epidemiology of tuberculosis in the United States. , 1989, Epidemiologic reviews.
[43] A. Vennema. The status of tuberculosis control in New York City. , 1982, Public health reports.
[44] R. Young,et al. Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines , 1991, Nature.
[45] R. Haley,et al. Tuberculosis epidemic among hospital personnel. , 1989 .
[46] R. O'brien,et al. USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results. , 1990, Annals of internal medicine.
[47] S. Kaufmann,et al. Mycobacterial protein antigens: a compilation , 1992, Molecular microbiology.
[48] Ronald Arbuthnott Knox,et al. On English translation , 1973 .
[49] L G Escobedo,et al. Behavioral Risk Factor Surveillance, 1988. , 1990, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.
[50] D. Mitchison. THE TUBERCLE BACILLUS , 1959 .
[51] J. E. Perkins,et al. Effect of Ultra-violet Irradiation of Classrooms on Spread of Measles in Large Rural Central Schools Preliminary Report. , 1947, American journal of public health and the nation's health.
[52] G. Rook. Role of activated macrophages in the immunopathology of tuberculosis. , 1988, British medical bulletin.
[53] H. G. ten Dam,et al. The effectiveness of BCG vaccination of the newborn against childhood tuberculosis in Bangkok. , 1986, Bulletin of the World Health Organization.
[54] P. Fine,et al. BCG vaccination against tuberculosis and leprosy. , 1988, British medical bulletin.
[55] M. Denis. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. , 1991, Cellular immunology.
[56] G. Schoolnik,et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. , 1992, The New England journal of medicine.
[57] M. Horwitz,et al. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. , 1990, Journal of immunology.
[58] A. Calmette. La vaccination preventive contre la tuberculose par le "BCG" , 1927 .
[59] S. Jonjić,et al. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.
[60] P. Barnes,et al. Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. , 1990, The American journal of medicine.
[61] M. Horwitz,et al. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium. , 1991, Journal of immunology.
[62] H. G. ten Dam,et al. The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African community. , 1986, Tubercle.
[63] M. J. Kuhar,et al. The dopamine hypothesis of the reinforcing properties of cocaine , 1991, Trends in Neurosciences.
[64] G W Comstock,et al. The prognosis of a positive tuberculin reaction in childhood and adolescence. , 1974, American journal of epidemiology.
[65] W. Jacobs,et al. New use of BCG for recombinant vaccines , 1991, Nature.
[66] O. Horwitz,et al. Epidemiological basis of tuberculosis eradication. 10. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area. , 1969, Bulletin of the World Health Organization.
[67] G. Rosen. National Tuberculosis Association 1904-1954. A Study of the Voluntary Health Movement in the United States , 1958 .
[68] R. Luzzati,et al. NOSOCOMIAL EPIDEMIC OF ACTIVE TUBERCULOSIS AMONG HIV-INFECTED PATIENTS , 1989, The Lancet.
[69] P. Brennan,et al. Structure, function and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance; some thoughts and possibilities arising from recent structural information. , 1991, Research in microbiology.
[70] W. Gross,et al. Base Composition of Deoxyribonucleic Acid Isolated from Mycobacteria , 1968, Journal of bacteriology.
[71] I. Orme,et al. Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. , 1984, Cellular immunology.
[72] P. Andersen,et al. T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis , 1991, Infection and immunity.
[73] A. Dannenberg. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. , 1991, Immunology today.